© Reuters.
On Monday, Cigna Corporation (NYSE:) received an upgrade in its stock rating by Cantor Fitzgerald, moving from Neutral to Overweight. The firm also increased its price target for the healthcare services provider to $372 from the previous $334.
Cantor Fitzgerald’s revision of Cigna’s outlook is based on the company’s promising earnings potential for the years 2025 and 2026. The analyst highlighted the role of Evernorth, Cigna’s health services platform, as a key driver for this anticipated growth. According to the analyst, Evernorth positions Cigna favorably in the market.
The firm also noted Cigna’s relatively low-risk profile amid current uncertainties in the Medicare space and the possibility of the insurance industry entering an underwriting cycle. This assessment suggests a belief in the company’s resilience and potential for stable performance despite sector-wide challenges.
The new price target of $372 represents a significant increase and reflects confidence in the company’s strategic positioning and expected financial performance in the coming years. This adjustment in the target price underscores the analyst’s positive outlook on Cigna’s growth trajectory.
Cigna’s stock rating upgrade and the raised price target come at a time when investors are closely monitoring the healthcare sector for signs of stability and growth potential. The revised rating and target by Cantor Fitzgerald provide a more optimistic view of Cigna’s market prospects.
InvestingPro Insights
Following the recent upgrade by Cantor Fitzgerald, Cigna Corporation (NYSE:CI) has been showing signs of robust financial health and market potential according to InvestingPro data. The company’s market capitalization stands at a substantial $94.76 billion USD, indicating a significant presence in the industry. With a current P/E ratio of 18.19 and an adjusted P/E ratio for the last twelve months as of Q3 2023 at 17.09, Cigna presents a potentially attractive value proposition for investors looking for stable earnings.
The company’s revenue growth has also been positive, with a 5.46% increase over the last twelve months as of Q3 2023, and an even higher quarterly growth rate of 8.48% in Q3 2023. This growth is a testament to Cigna’s strong market position, further bolstered by Evernorth’s contributions, as highlighted by Cantor Fitzgerald. Additionally, Cigna’s dividend yield stands at 1.73%, with an impressive dividend growth rate of 25.0% over the last twelve months, which may appeal to income-focused investors.
InvestingPro Tips also reveal that Cigna has been a consistent performer, maintaining dividend payments for an impressive 43 consecutive years. Moreover, the stock has recently experienced a significant return, with a one-week price total return of 8.35%. This indicates a bullish trend for the stock in the short term, aligning with Cantor Fitzgerald’s optimistic outlook.
For investors seeking more in-depth analysis and additional insights, InvestingPro offers a range of tips. There are currently over 10 additional InvestingPro Tips available for Cigna, accessible through an InvestingPro+ subscription. Additionally, for those looking to capitalize on the New Year sale, InvestingPro is offering up to 50% off on subscriptions. Use coupon code SFY24 for an extra 10% off a 2-year InvestingPro+ subscription, or SFY241 for an additional 10% off a 1-year subscription.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
